Related Experiment Videos
A new ventilation tube for long-term middle ear ventilation
P Bonvin1, B Bakke Hansen, E Hentzer
1Department of Otolaryngology, Fyn Hospital, Svendborg, Denmark. Bonvin@lycos.com
The Laryngoscope
|November 20, 2002
Summary
The Duravent tube offers a longer in-situ duration for treating secretory otitis media, significantly reducing tympanic membrane perforations and complications compared to T-tubes.
Area of Science:
- Otolaryngology
- Biomaterials Science
- Medical Device Engineering
Background:
- Secretory otitis media often necessitates repeated tympanic membrane ventilation.
- Standard ventilation tubes have short in-situ duration, leading to frequent re-tubulation.
- Existing long-term tubes like T-tubes have high rates of complications such as perforations and granulations.
Purpose of the Study:
- To evaluate the efficacy of the Duravent tube for middle ear ventilation.
- To compare the in-situ duration and complication rates of the Duravent tube with standard and T-tubes.
- To assess the long-term outcomes of Duravent tube use in patients with secretory otitis media.
Main Methods:
- Retrospective study design.
- Inclusion of 51 patients treated with 72 Duravent tubes over a 2-year period.
- Follow-up examination at a median of 28 months (range 11-43 months) with a 5-year follow-up period.
Main Results:
- The Duravent tube demonstrated an optimal median in-situ duration of 17 months.
- Spontaneous extrusion occurred in most cases, with only four requiring surgical removal.
- Low rates of persisting tympanic membrane perforations (4.2%) and fewer complications (14%) were observed compared to T-tubes (24% and 35%, respectively).
Conclusions:
- The Duravent tube is superior to existing long-term ventilation tubes for secretory otitis media.
- Significantly reduced incidence of granulations, otorrhoea, and tube occlusion compared to T-tubes.
- Duravent tube represents an improved option for long-term middle ear ventilation with fewer adverse events.